The same study also demonstrated increased levels of S100B in AD patients, which is a molecule secreted by astrocytes and is both associated with trophic and toxic effects, such as increased pro-inflammatory cytokines and influxes of Aβ at the blood–brain barrier via the S100B/RAGE pathway. This evidence concerns the gene S100B and Alzheimer disease.